However, mice with mutations in Kras2 and Trp53 are highly predisposed to other cancers (101, 102) and cancer development can be triggered by spontaneous oncogene recombination events; thus these models are not necessarily lung cancer specific and therefore some mechanisms of carcinogenesis may not accurately recapitulate human disease (99, 100). Here, KRAS is linked to lung carcinoma.